The Wegovy Pill Is Here: How the First Oral GLP-1 Could Reshape a $50 Billion Market
Novo Nordisk's oral Wegovy pill launches in January 2026, marking a turning point for the $50 billion weight-loss drug market. Here's what investors need to know.
1366 articles found for "investing"
The January Effect: 4 Beaten-Down Growth Stocks Primed for an Early 2026 Rebound
The January Effect could spark rallies in oversold growth stocks. Here are four names—nCino, Global-e, GitLab, and Samsara—that analysts say are poised to bounce.
TSMC: Why Wall Street Sees Taiwan Semiconductor as 2026's Best AI Play
Taiwan Semiconductor rose 50% in 2025 but analysts say the AI chipmaker remains undervalued heading into 2026. Here's why TSMC could be the year's top performer.
The Earnings Paradox: Wall Street Expects 15% Profit Growth, But Valuations Echo the Dot-Com Era
Analysts project robust 15% S&P 500 earnings growth in 2026, but with P/E ratios near dot-com levels, stocks may struggle to advance despite strong profits.
The Great Earnings Convergence: Why the 'Other 493' S&P 500 Stocks Finally Catch Up in 2026
After years of Magnificent Seven dominance, the earnings gap is finally narrowing. Here's why the rest of the S&P 500 could outperform Big Tech in 2026.
The $1 Trillion Chip Surge: Why 2026 Could Be the Semiconductor Industry's Most Historic Year
Bank of America predicts global semiconductor sales will surge 30% to finally cross the $1 trillion milestone in 2026, led by Nvidia and AI demand.
Morgan Stanley Sees Dollar Falling Further in 2026 Before Late-Year Rebound
Morgan Stanley forecasts the U.S. dollar index will drop to 94 by Q2 2026 before recovering to 100 by year-end. Here's what the dollar's trajectory means for investors.
Tesla's Make-or-Break Week: Q4 Deliveries Will Reveal Whether 2025 Marks Second Straight Annual Decline
Tesla will report Q4 2025 deliveries this week. With analysts expecting 420,000 vehicles, the results will confirm whether the EV giant posted its second consecutive year of declining sales.
Banking's Breakout Year: Why 2026 Could Be the Best in a Decade for Financial Stocks
Lower rates, improved capital markets activity, and deregulation create the perfect setup for bank stocks in 2026. Here are three themes and top picks to watch.
Fixed Income's Moment: Why Bond Investors Could Outperform Stock Pickers in 2026
With stocks trading at 30x earnings and bond yields near 4%, fixed income may offer better risk-adjusted returns in 2026. Here's the case for shifting toward bonds.
Bitcoin's Crossroads: Wall Street Divided Between $250,000 Dreams and Crypto Winter Fears
As 2026 begins, crypto analysts are split between extreme bullish and bearish predictions. One analyst sold his house to bet on a $250K Bitcoin. Others warn of an extended bear market.
Private Credit Hits $30 Trillion: Why Wall Street's Hottest Asset Class Is Just Getting Started
BlackRock, Morgan Stanley, and institutional investors are pouring billions into private credit as the alternative asset class expands beyond traditional lending.